Author:
Dimitrios Farmakiotis, MD Jeffrey J. Tarrand, MD Dimitrios P. Kontoyiannis, MD, ScD, FIDSA
Full conference title:
IDWeek 2015 San Diego, CA
Date: 14 November 2017
Abstract:
Background. Central venous catheter (CVC) removal is beneficial in patients with CVC-related candidemia, defined as a higher colony count in a catheter lumen, compared to peripheral blood. However, clinicians are often faced with a blood culture growing Candida in a patient with a CVC, and few laboratories perform quantitative cultures. Therefore, it was proposed that short time-to-culture positivity (TTP) can be suggestive of catheter-related candidemia, in series of predominantly C. albicans candidemia episodes. Given the epidemiologic shift to non-albicans Candida species, and the longer time to detection for C. glabrata, compared to other Candida species, we studied the clinical characteristics of patients with CVC-related C. glabratafungemia and the diagnostic utility of time-to-reporting (TTR) of positive blood cultures.
Methods. We included patients with at least one blood culture(s) positive for C. glabrata, a CVC and available TTR, seen at MD Anderson Cancer Center between March 2005 and September 2013. CVC-related candidemia was defined as a colony count in a blood culture obtained via the CVC at least fivefold greater than the colony count in peripheral blood.
Results. Fifty-six of 119 patients studied (49%) were deemed to have CVC-related candidemia. Those patients were less likely to be on total parenteral nutrition (TPN, 34 [42%] versus 48 [59%] of those with non-CVC-related candidemia, P = 0.01), or have an absolute neutrophil count <100/μL (2 [4%] versus 13 [22%], P < 0.01). TTR was shorter in patients with CVC-related candidemia (mean ± standard deviation, 67 ± 35 hours) compared to those with non-CVC-related candidemia (79 ± 31 hours, P < 0.01), and had significant diagnostic value by ROC analysis (figure). A TTR <48 hours was 99% specific for CVC-related candidemia.
Conclusion. Among patients with C. glabrata fungemia, an abdominal source was more likely than CVC-related candidemia in severely neutropenic patients and in those receiving TPN. In the evaluation of patients with C. glabrata fungemia, a TTR of <48 hours could further support the decision to remove the CVC.
Disclosures. All authors: No reported disclosures.
Conference Year: 2015
Link to conference website: IDWeek 2015
Tables:
Link Conference abstract:
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
D Luptáková1*, RH Patil1,2, R Dobiáš3,4, DA Stevens5,6, T Pluháček1,2, A Palyzová1, A Škríba1, V Havlíček1,2
2022
23
-
v
Y Bahri*, S Ben.Belgacem, Y Maatouk, A Ben.Salah, M Mastouri
2022
22
-
v
Y Bahri*, S Ben.Belgacem, Y Maatouk, A Ben.Salah, M Mastouri
2022
21
-
v
A Knaz1, A Omrane1, H Chouaieb2, M Chatti2, R Mrassi2, S Ismail2, M Ben Seif2, W Benzarti1, MA Ayed1, A Abdelghani1, A Hayouni1, S Aissa1, I Gargouri1, A Fathallah2*
2022
20
-
v
A Azzabi1, O Mahfoudh1, N Ben Aicha1, W Sahtout1, A Ayadi2, Z Lajmi3, M Smida4, H Chouaieb4, M Chatti4, S Ismail4, R Boukadida1, F Sabri 1, S Ben Amor1, D Zellama1, S Hmissa3, H Kochtali2, A Fathallah4*, Y Guedri1, A Achour1
2022
19
-
v
M Smida1, A Meherzi2, H Chouaieb1, M Chatti1, M Ben Seif1, R Hajlaoui1, M Abdelkefi2, A Fathallah1*
2022
18
-
v
M Sahu1*, M Shah2, MV Rao3, VR Kola4, HK Boorugu5, AR Punjani6, RV Kumar7, S Kumar8, M Manusrut9, RK Rathod10, HK Gonuguntla11, GK Yedlapati12, GR Mallu13, YS Reddy14, RN KomalKumar15, GS Jaishetwar16, KR Balasubramoniam17, SCR Kumar18, B Nagaraju19, PR Sahoo20
2022
17
-
Chronic pulmonary aspergillosis among presumed tuberculosis patients at a tertiary hospital in Ghana
v
BK Ocansey1*, A Adjei2, H Gbadamosi3, C Kosmidis1,4, J Afriyie-Mensah2,5, JO Opintan6, DW Denning1
2022
16
-
v
CD de La Porte1*, CP Provost2, AS Serris1, AC Coste3, MB Bougnoux4, RB Herbrecht5, VB Bru6, FA Ader7, FP Persat8, EC Canet9, FM Morio10, BD Denis11, AA Alanio12, LL Lelièvre13, SC Cassaing14, RS Sonneville15, LM Millon16, OL Lortholary1, ON Naggara2, FL Lanternier1, French Cerebral Mucormycosis Study Group
2022
14